We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+36.08%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+531.4%
AUM
$4.08B
AUM Growth
+$236M
Cap. Flow
-$708M
Cap. Flow %
-17.33%
Top 10 Hldgs %
19.32%
Holding
5,845
New
764
Increased
1,966
Reduced
2,392
Closed
665

Sector Composition

Rank Sector Weight
1 Miscellaneous 34.65%
2 Technology 23.8%
3 Financials 7.62%
4 Industrials 7.22%
5 Healthcare 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYRX icon
2951
CryoPort
CYRX
$883M
$38.8K ﹤0.01%
2,469
-1,456
-37% -$18.7K
ALTO icon
2952
Alto Ingredients
ALTO
$285M
$38.7K ﹤0.01%
+6,784
New +$34.6K
GOLD
2953
Gold.com Inc
GOLD
$1.26B
$38.7K ﹤0.01%
929
-772
-45% -$33.2K
CCCC icon
2954
C4 Therapeutics
CCCC
$373M
$38.6K ﹤0.01%
8,269
-1,580
-16% -$5.4K
TROX icon
2955
Tronox
TROX
$639M
$38.6K ﹤0.01%
6,122
-2,861
-32% -$24.3K
PBYI icon
2956
Puma Biotechnology
PBYI
$506M
$38.5K ﹤0.01%
4,752
+2,184
+85% +$16K
SXC icon
2957
SunCoke Energy
SXC
$810M
$38.5K ﹤0.01%
4,779
-7,175
-60% -$55.4K
KOP icon
2958
Koppers
KOP
$877M
$38.4K ﹤0.01%
856
-1,064
-55% -$43.5K
CZFS icon
2959
Citizens Financial Services
CZFS
$391M
$38.4K ﹤0.01%
530
-811
-60% -$53.5K
PDLB icon
2960
Ponce Financial Group
PDLB
$488M
$38.4K ﹤0.01%
1,924
+757
+65% +$13.8K
MLAB icon
2961
Mesa Laboratories
MLAB
$746M
$38.3K ﹤0.01%
385
-96
-20% -$9.66K
BF.A icon
2962
Brown-Forman Class A
BF.A
$12.1B
$38.3K ﹤0.01%
1,398
+1,056
+309% +$29K
EVMN
2963
Evommune Inc
EVMN
$303M
$38.2K ﹤0.01%
2,872
+623
+28% +$14.5K
NVEC icon
2964
NVE Corp
NVEC
$529M
$38.2K ﹤0.01%
365
-925
-72% -$84.2K
AQST icon
2965
Aquestive Therapeutics
AQST
$592M
$38.1K ﹤0.01%
9,170
+679
+8% +$2.86K
PSNL icon
2966
Personalis
PSNL
$1.74B
$37.9K ﹤0.01%
2,832
-15,296
-84% -$124K
CDNA icon
2967
CareDx
CDNA
$3.3B
$37.9K ﹤0.01%
1,330
-3,393
-72% -$73.9K
EMBC icon
2968
Embecta
EMBC
$335M
$37.9K ﹤0.01%
11,624
+6,378
+122% +$34.8K
OBT icon
2969
Orange County Bancorp
OBT
$510M
$37.9K ﹤0.01%
1,030
-528
-34% -$18.4K
GTM
2970
ZoomInfo Technologies
GTM
$1.04B
$37.9K ﹤0.01%
12,926
-78,680
-86% -$354K
NXDR
2971
Nextdoor Holdings
NXDR
$936M
$37.7K ﹤0.01%
16,598
+3,438
+26% +$6.42K
IUSB icon
2972
iShares Core Universal USD Bond ETF
IUSB
$47.4B
$37.7K ﹤0.01%
816
+766
+1,532% +$35.3K
PCB icon
2973
PCB Bancorp
PCB
$389M
$37.6K ﹤0.01%
1,326
-632
-32% -$15.7K
ESI icon
2974
Element Solutions
ESI
$8.54B
$37.6K ﹤0.01%
787
-1,904
-71% -$79K
AMBP icon
2975
Ardagh Metal Packaging
AMBP
$2.62B
$37.5K ﹤0.01%
7,902
-2,330
-23% -$9.57K

Similar funds

Tower Research Capital (TRC)'s Q2 2026 Portfolio in Review

As of Q2 2026, Tower Research Capital (TRC) held 5,845 positions worth $4.08B, up 6.1% from $3.85B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) withdrew a net $708M in Q2 2026, closing 665 positions and reducing 2,392 holdings. Its most notable exit was iShares MSCI USA Min Vol Factor ETF, an estimated $13M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 29% a quarter earlier, followed by Technology and Financials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $84M.

  • Tower Research Capital (TRC)'s largest Q2 2026 buy was iShares Core S&P 500 ETF: 112,156 shares worth $84M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $130M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2026 reduction was Direxion Daily Semiconductor Bull 3X ETF, cutting an estimated $361M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Min Vol Factor ETF in Q2 2026, selling an estimated $13M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $4.08B portfolio in Q2 2026.
  • Tower Research Capital (TRC) opened 764 new positions and closed 665 in Q2 2026.
  • Tower Research Capital (TRC)'s portfolio value rose 6.1% quarter-over-quarter to $4.08B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.